| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 10/09/2001 | US6300332 Methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| 10/09/2001 | US6300323 (Poly)ethereal ammonium salts of herbicides bearing acidic moieties and their use as herbicides |
| 10/04/2001 | WO2001072960A2 Il-8 receptor antagonists |
| 10/04/2001 | WO2001072728A2 Novel piperazine derivatives |
| 10/04/2001 | WO2001072687A1 Diphenyl ether compounds useful in therapy |
| 10/04/2001 | WO2001046144A8 New modulators of dopamine neurotransmission |
| 10/04/2001 | WO2001021577A3 Melanin concentrating hormone antagonist |
| 10/04/2001 | US20010027211 Anticarcinogenic, -inflammatory and -proliferative agents; viricides; bactericides; vascular restenosis, autoimmune diseases; psoriasis; anticolesterol and -lipemic agents |
| 10/04/2001 | US20010027202 Antitumor and -carcinogenic agents; solid cancers, e.g carcinomas of the lungs, pancreas, thyroid, bladder or color, myeloid disorders, e.g. leukemia or adenomas, e.g villous colon adenoma |
| 10/04/2001 | EP1138745A1 Organic electroluminescent element |
| 10/04/2001 | EP1138678A2 Process for making N-((4-phenyl) methylphenyl) piperazines |
| 10/04/2001 | EP1137647A1 Thiourea inhibitors of herpes viruses |
| 10/04/2001 | EP1137633A2 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| 10/04/2001 | EP1137632A1 Thiourea inhibitors of herpes viruses |
| 10/04/2001 | EP1137628A1 Molecular scaffolds acting as templates comprising carbamate linkages |
| 10/04/2001 | EP1137410A1 Novel 4-dedimethy laminotetra cycline derivatives |
| 10/04/2001 | EP0815074B1 O-carbamoyl-(d)-phenylalanilol compounds and process for preparing the same |
| 10/04/2001 | EP0688314B1 Prodrug derivatives of enzyme inhibitors with hydroxyl groups, methods of preparing them and their use |
| 10/04/2001 | EP0613465B1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents |
| 10/04/2001 | CA2404626A1 Novel piperazine derivatives |
| 10/04/2001 | CA2404439A1 Diphenyl ether compounds useful in therapy |
| 10/04/2001 | CA2403787A1 Il-8 receptor antagonists |
| 10/03/2001 | CN1315945A Nitrate salts of antihypertensive medicines |
| 10/03/2001 | CN1072230C Process for regenerating aqueous process fluid from amine oxide process |
| 10/03/2001 | CN1072222C Phenyloxazolidinones having C-C bond to 4-8 membered heterocyclic rings |
| 10/03/2001 | CN1072215C Amorphous piretanide, piretanide polymorphs, process for their preparation and their use |
| 10/02/2001 | US6297277 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 10/02/2001 | US6297260 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 10/02/2001 | US6297247 Particularly stromelysin-1 and gelatinase a (72 kd gelatinase) |
| 10/02/2001 | US6297217 Boronic ester and acid compounds, synthesis and uses |
| 10/02/2001 | CA2250092C Triaryl and diaryl compounds, their analogues and uses thereof |
| 10/02/2001 | CA2093609C Color development composition and method of processing silver halide colour photographic material using the same |
| 10/02/2001 | CA2056137C Process for cleaning or purifying aqueous n-methylmorpholine-n-oxide solutions |
| 09/27/2001 | WO2001070757A2 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 09/27/2001 | WO2001070720A2 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | WO2001070684A2 Peptidomimetic ligands for cellular receptors and ion channels |
| 09/27/2001 | WO2001070682A2 Carbocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | WO2001070677A1 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 09/27/2001 | WO2001070675A2 Inhibitors of histone deacetylase |
| 09/27/2001 | WO2001070674A1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 09/27/2001 | WO2001070672A2 Compounds and methods to treat alzheimer's disease |
| 09/27/2001 | WO2001070671A2 Insecticidal anthranilamides |
| 09/27/2001 | WO2001070670A1 Novel phenylalanine derivative |
| 09/27/2001 | WO2001070669A2 Process for forming an amide bond |
| 09/27/2001 | WO2001004115A3 Novel process for synthesis of heteroaryl-substituted urea compounds |
| 09/27/2001 | WO2000061537A3 Pharmaceutical compounds |
| 09/27/2001 | US20010025105 Anticancer agent; Alzheimer's therapy |
| 09/27/2001 | US20010025052 Novel nitric oxide-releasing amidine- and enamine-derived diazeniumdiolates, compositions and uses thereof and method of making same |
| 09/27/2001 | US20010025051 Administering to a breast cancer patient an effective amount of hydroxy containing bicyclic aromatic or heteroaromatic derivatives |
| 09/27/2001 | US20010025041 Amidino protease inhibitors |
| 09/27/2001 | CA2404236A1 Carbocyclic side chain containing, n-substituted metalloprotease inhibitors |
| 09/27/2001 | CA2404094A1 Process for forming an amide bond |
| 09/27/2001 | CA2404002A1 Inhibitors of histone deacetylase |
| 09/27/2001 | CA2403823A1 Thioketals and thioethers for inhibiting the expression of vcam-1 |
| 09/27/2001 | CA2403778A1 Carbocyclic side chain containing metalloprotease inhibitors |
| 09/27/2001 | CA2401749A1 Compounds and methods to treat alzheimer's disease |
| 09/26/2001 | EP1135379A1 Antitumor dibenzofluorene derivatives |
| 09/26/2001 | EP1135378A1 Benzamide derivatives and their use as apob-100 secretion inhibitors |
| 09/26/2001 | EP1135369A2 Alpha-sulfin- and alpha-sulfonamino acid amides |
| 09/26/2001 | EP0762887B1 Acylated enol derivatives as prodrugs of elastase inhibitors |
| 09/26/2001 | CN1314883A Amino acid derivatives and drug containing the same as the active ingredient |
| 09/26/2001 | CN1071751C Reversible protease inhibitors |
| 09/26/2001 | CN1071750C Process for selective separation of morpholine |
| 09/26/2001 | CN1071738C Carboxylic derivatives exhibiting phospholipase A2 inhibitory activity |
| 09/25/2001 | US6294698 Photoinitiators and applications therefor |
| 09/25/2001 | US6294580 For therapy and prophylaxis of type ii or non-insulin dependent diabetes mellitus, hyperglycaemia, dyslipidemia, type ii diabetes, type i diabetes, hypertriglyceridemia, syndrome x, insulin resistance, heart failure |
| 09/25/2001 | US6294556 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 09/25/2001 | US6294533 Calcium channel blockers |
| 09/25/2001 | US6294531 Calcilytic compounds |
| 09/25/2001 | US6294517 Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use |
| 09/25/2001 | CA2214601C Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 09/20/2001 | WO2001068645A2 N-cyanomethylcarboxamides and their use as protease inhibitors |
| 09/20/2001 | WO2001068643A2 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 09/20/2001 | WO2001068622A1 Novel cyclobutene derivatives useful as antagonists of the motilin receptor |
| 09/20/2001 | WO2001068621A1 Novel cyclohexene derivatives useful as antagonists of the motilin receptor |
| 09/20/2001 | WO2001068619A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | WO2001068612A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 09/20/2001 | WO2001068599A2 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 09/20/2001 | WO2001068585A1 Novel amide compounds |
| 09/20/2001 | WO2001068575A1 Fluoroalkylonium salt type cation or acid generator generating cation or acid upon irradiation with energy ray |
| 09/20/2001 | WO2001068084A1 Il-8 receptor antagonists |
| 09/20/2001 | WO2001068033A2 Il-8 receptor antagonists |
| 09/20/2001 | WO2001034591A3 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 09/20/2001 | WO2000047553A8 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa |
| 09/20/2001 | WO2000027378A3 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 09/20/2001 | US20010023305 By direct reaction of an amine with an alpha, gamma-dihaloalkane or an alpha, gamma-dihaloalkene; tertiary aminoalkylorganometallics can be made by then reacting the tert haloalkylamines with an alkali metals |
| 09/20/2001 | US20010023249 Calcium channel blockers |
| 09/20/2001 | US20010023240 Compounds and compositions for delivering active agents |
| 09/20/2001 | US20010022961 Zeolite SSZ-52 |
| 09/20/2001 | EP1143960A3 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 09/20/2001 | CA2403062A1 Il-8 receptor antagonists |
| 09/20/2001 | CA2403017A1 5-amide substituted diarylamines as mex inhibitors |
| 09/20/2001 | CA2402898A1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 09/20/2001 | CA2402746A1 Dosing form for reagents, use of said dosing form in organic chemical synthesis and production of said dosing form |
| 09/19/2001 | EP1133471A1 Hydrazine derivatives |
| 09/19/2001 | EP0800516B1 FIBRINOGEN RECEPTOR ANTAGONISTS HAVING SUBSTITUTED (b)-AMINO ACID RESIDUES AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME |
| 09/19/2001 | CN1313847A Method for preparing alkoxyamines from nitroxides |
| 09/19/2001 | CN1313035A Herbicidal composition and use thereof |
| 09/19/2001 | CN1071329C Aryl glycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 09/19/2001 | CN1071328C Arginine angalogues having nitric oxide synthase inhibitor activity |